Shares of Merck & Co. Inc. MRK dropped 0.58% to $114.96 Tuesday, on what proved to be an all-around positive trading session ...

Thank you for attending our Global Healthcare Conference. Today, I have the pleasure to host Joe Romanelli, President of Human Health International; and Peter Dannenbaum, Head of Investor Relations.

The recipients of the Merck Animal Health Bovine Veterinary Student Recognition Award were selected based on their academic ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA announced it has awarded $20,000 in scholarships to two ...

We recently compiled a list of the 10 Best Defensive Stocks According to Reddit. In this article, we will look at where Merck ...

If you’re ready for a career change but you don’t fancy going back to school or spending money on courses or qualifications, the good news is that there are plenty of opportunities that offer ...

MilliporeSigma is partnering with the Emmy® and Golden Globe® Award-winning ABC series “Abbott Elementary” to increase access ...

Merck’s cancer immunotherapy Keytruda is the drug industry’s biggest blockbuster, bringing in $25 billion in sales last year. For years drug companies have sought to beat the therapy to no avail.

Merck (MRK) shares fell when Summit Therapeutics (SMMT) reported positive results from a Phase 3 trial of a lung cancer drug that could rival Merck's Keytruda. Summit Therapeutics shares soared to ...

Shares of Summit Therapeutics Inc. jumped more than 30% premarket on Monday after the biotech company released late-stage trial data showing that its experimental lung-cancer treatment topped ...

Avelumab is under clinical development by Merck and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...